
The provided droppers may have been mislabeled.

NASP takes aim at DIR fees.

A 5% drop in MMR vaccine use could lead to as much as $4.1 million in health-care costs.

Parents of teenagers are often unaware that their teen children have not had all the vaccinations they need.

Maybe the health-care industry could learn something from Pete Kreckel's mother.

How can we better engage patients for greater adherence rates?

Pharmacists are a source of education for students and parents.

Why are residency programs becoming harder to find?

Patients need more help managing complicated meds than ever-and pharmacists are there to help.

The first test store in Des Plaines could be just the start.

The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.

The failed Rite Aid/Walgreens merger might mean the end of business as usual.

Is your pharmacy's refrigerator maintaining the right temperature?

International Laboratories recalling one lot of bottles labeled 40-mg pravastatin.

When drug prices spike, health-care providers are forced to make tough choices.

FDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.

Class action lawsuits claim that chains colluded with PBMs to overbill customers.

New research suggests that the latest trend in opioids may not be so helpful.

The recall affects a variety of distributors.

Pharmacy chains are forcing lower generic prices for their customers.

A youth education campaign about e-cigarettes is part of FDA’s tobacco/nicotine plan.

Here's the technology your pharmacy might have in the next 10 years.

How the FDA is prioritizing drugs that offer the biggest health gains.

The agency says that the reduction lines up with current demand for opioids.

How one product is making it easier for your patients to safely dispose of their medications.

Big changes for EpiPen and more in Express Scripts’ formulary.

A new study shows that supplement exposure rates have been increasing-pharmacists have a responsibility to slow those rates.

A compounding fraud scheme cost taxpayers millions-and could put two pharmacists in prison.

Aspace Packaging recalls two drugs due to potential mislabeling.

Looking for a new pharmacy job? You should probably avoid these states.